<DOC>
	<DOCNO>NCT01187667</DOCNO>
	<brief_summary>Haloperidol prescribe high risk ICU patient concern delirium ( 50 % chance develop delirium detected delirium prediction model PRE-DELIRIC , patient history dementia alcohol abuse ) since delirium protocol change haloperidol added prevention treatment gather information effect several aspect delirium</brief_summary>
	<brief_title>Evaluation Delirium Prevention Critically Ill Patients</brief_title>
	<detailed_description>Measurement effect haloperidol delirium preventive intervention . Determining effect : - delirium incidence ICU - different subtypes delirium - delirium free day 28 day - day ventilator - length stay ICU In-Hospital - 28-day mortality - incidence unexpected removal tube , effect different group patient . Safety haloperidol concern QT-time , extrapyramidal symptom . Data compare data historical cohort</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>Patients With Predicted Delirium Chance &gt; 50 % history dementia alcohol abuse treat haloperidol CAMICU Not Applicable Patients Admitted 24hours Shorter ICU , Patients Who Are Delirious Within 24 Hours After ICU Admission patient whereby haloperidol contraindicate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>delirium</keyword>
	<keyword>prevention</keyword>
	<keyword>critical care</keyword>
	<keyword>haloperidol</keyword>
</DOC>